November 06, 2026 at 10:29 PM UTC
bioAffinity Technologies, Inc. reports financial results in SEC 8-K
bioAffinity Technologies, Inc. filed an 8-K covering results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 06, 2026 at 10:28 PM UTC
Open official source